The role of organoids in cancer research.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Competing interestsThe authors declare no competing interests. AbbreviationsThree-dimensional (3D); Patient-derived tumor organoids (PDTOs); Extracellular Matrix (ECM); Engelbreth-Holm-Swarm (EHS); Mesenchymal stem cells (MSC); Induced Pluripotent Stem Cells (iPSCs); EGF, Noggin, R-spondin (ENR); Colorectal cancer (CRC); Embryonic stem cells (ESCs); Adult stem cells (ASCs); Human pluripotent stem cell (hPSC); Circulating tumor cells (CTCs); Patient Derived Organoid (PDO); Rhabdomyosarcomas (RMS); Tumor-infiltrating lymphocytes (TILs); Food and Drug Administration (FDA); β-hydroxybutyrate (BHB); Cancer-associated fibroblasts (CAFs). Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interests The authors declare no competing interests."
"Funding This paper was supported by the National Natural Science Foundation of China (82203854); Key Research and Development Program of Shandong Province (No.2019JZZY010104; 2021CXGC011104); Special Foundation for Taishan Scholars Program of Shandong Province (No.ts20190978); Academic promotion programme of Shandong First Medical University (No. 2019QL021)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025